Various human solid tumors highly express IL-4 receptors which amplify the expression of some of anti-apoptotic proteins, preventing drug-induced cancer cell death. Thus, IL-4 receptor targeted drug delivery can possibly increase the therapeutic efficacy in cancer treatment. Macromolecular carriers with multivalent targeting moieties offered great advantages in cancer therapy as they not only increase the plasma half-life of the drug but also allow delivery of therapeutic drugs to the cancer cells with higher specificity, minimizing the deleterious effects of the drug on normal cells. In this study we designed a library of elastin like polypeptide (ELP) polymers containing tumor targeting AP1 peptide using recursive directional ligation method. AP1 was previously discovered as an atherosclerotic plaque and breast tumor tissue homing peptide using phage display screening method, and it can selectively bind to the interleukin 4 receptor (IL-4R). 
Introduction
Targeted macromolecular polymer carriers offer the potential of effective drug delivery by virtue of their ability to decrease the rate of drug clearance after systematic administration and improve the plasma half-life of drugs [1] . One such engineered biopolymer is elastin-like polypeptide (ELP), which is an emerging drug carrier under development for cancer therapy. In several cancer models, ELPs have already been used for targeted delivery of small molecules drugs (doxorubicin) [2, 3] , therapeutic peptides (c-Myc inhibitory peptide) [4] and proteins [5] . They have unique characteristics compared to other polymeric drug delivery systems, including low toxicity, good biodegradability, and biocompatibility [6, 7] . ELP biopolymers are derived from the structural motif found in mammalian elastin protein, which consists of the pentapeptide repeat, Val-Pro-Gly-Xaa-Gly (VPGXG), where Xaa (''guest'' residue) can be any amino acid except proline [8, 9] . ELP polymers can be synthesized at the genetic level using recombinant DNA methods; thus, their sequence, composition, and molecular weight can be controlled. Accordingly, the hydrophobicity and degree of ionization can be precisely tuned for proper tissue distribution and subcellular uptake [10, 11] . Moreover, the numbers of targeting peptides or specific reactive sites for drug conjugation can be incorporated at the genetic level along with the ELP sequence, which is one of the difficulties to accomplish using synthetic polymers. ELPs are soluble in aqueous solutions below their transition temperature (T t ), but hydrophobically collapse and aggregate at temperatures greater than T t [12, 13] . This inverse transition temperature is fully reversible. The transition temperature of ELP can be controlled by varying the guest residue, molecular weight and concentration [10] . Notably, ELPs can be easily expressed and purified at high yield simply by exploiting inverse temperature cycling (ITC) method [14, 15] .
Using phage display screening, we previously discovered an atherosclerotic plaque and breast tumor tissue homing peptide, CRKRLDRN, termed AP1 peptide that selectively binds to the interleukin -4 receptors (IL-4Rs) [16] [17] [18] . IL-4Rs are highly expressed in a wide variety of human tumors, including renal cell carcinoma, squamous cell carcinoma of the head and neck, malignant glioma, AIDS-associated Kaposi's sarcoma and breast cancer cell lines [19] [20] [21] [22] . It has been reported that IL-4/IL-4R interactions amplify the expression of some anti-apoptotic proteins, including PED/PEA15 (15 kDa phosphoprotein enriched in astrocytes), cFLIP/CFLAR (CASP8 and FADD-like apoptosis regulator), and the BCL family proteins Bcl-xL and Bcl, thereby preventing drug-induced cancer cell death [23, 24] . Thus, targeting the IL-4R could possibly increase the therapeutic efficacy of anticancer drugs. Even though AP1 peptide possesses high target-specificity and efficient tumor-homing, it has limitation due to easy elimination from the circulation and short half-life.
The aim of this study is to increase the stability and binding affinity of the AP1 peptide in vivo, and thus increase its utility, through multivalent presentation of the AP1 peptide in an ELP polymer backbone. Many studies have demonstrated that the presentation of multiple targeting moieties on a polymer backbone can improve binding avidity and specificity compared to monovalent ligand presentation [25] . Accordingly, we designed and prepared a series of an AP1 peptide containing ELP polymer using recursive directional ligation (RDL) method and analyzed the characteristics and the efficacy in vitro and in vivo. The binding specificity of [AP1-V 12 ] 6 polymer towards cancer cells was analyzed using confocal microscopy and flow cytometry, and in vivo optical imaging in a tumor xenograft mouse model. The studies have revealed that the incorporation of multivalent targeting peptide ligand into ELP polymer facilitated the greater targeting to IL-4R expressing cancer cells.
Materials and Methods

Media and cell culture
H226 (human lung cancer cells), MDA-MB-231 (human breast cancer cells), and H460 (human lung cancer cells) were obtained from American Type Culture Collection (ATCC). H226 and H460 cells were grown in RPMI-1640 (Hyclone, Thermo Scientific, Logan, UT), and MDA-MB-231 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Hyclone, Thermo Scientific) supplemented with 10% fetal bovine serum (Hyclone, Thermo Scientific) and 100 U/mL penicillin and 100 mg/mL of streptomycin (Sigma Aldrich, St. Louis, MO, USA). Cells were maintained at 37uC in a humidified atmosphere containing 5% CO 2 .
Designing of monomer gene and oligomerization
Synthetic oligonucleotides encoding genes of [VGVPG] 14 and VGRKRLDRNG[VGVPG] 12 referred as V 14 and AP1-V 12 were designed to contain BamH I and HinD III compatible cohesive ends upon annealing, which allows the annealed product to be directly ligated into a BamH I and HinD III-cleaved pRSET B+ vector (Invitrogen, CA, USA) [26, 27] for 1 h at 4uC. After washing with PBS for two times, cells were suspended with 300 ml of PBS and analyzed by flow cytometry. 10,000 events were analyzed for each sample.
Confocal Microscopy
H226, MDA-MB-231 and H460 cells were seeded on four chambered slide and grown to 80% confluence. Cells were then incubated with 10 mM Alexa 488 labeled [V 14 ] 6 and [AP1-V 12 ] 6 proteins and AP1 peptides for 1 h at 4uC and 37uC. Unbound peptides were washed out with PBS, and cells were fixed with 4% paraformaldehyde (Sigma Aldrich). Cell nuclei were stained with 49,6-diamidino-2-phenylindole (DAPI; Sigma Aldrich), and chamber slides were mounted with anti-fade reagent (Invitrogen). Images were captured and analyzed in sequential scanning mode using a Zeiss LSM-510 Meta confocal microscope.
Cell viability and proliferation assay 
Surface Plasmon Resonance (SPR) analysis
Interactions of AP1, [V 14 ] 6 and [AP1-V 12 ] 6 with the IL-4R were analyzed at 25uC using a surface plasmon resonance instrument (Reichert Life Sciences, NY, USA). IL-4Ra (CD124) (Sino Biological, Beijing, China) was immobilized by activating the carboxy methyl group on dextran-coated chips (Reichert Life Sciences) through a reaction with N-hydroxysuccinimide (Sigma Aldrich), followed by covalent bonding of the ligands to the chip surface via amide linkages and blocking of excess activated carboxyls with ethanolamine. Different concentrations of AP1 peptide (3.125 to 50 mM) and [AP1-V 12 ] 6 (125 nM to 1 mM) in binding buffer were allowed to flow over surfaces containing immobilized IL-4Ra (20006400 RU) for 3 min at a rate of 25 mL/min. The sensor surface was regenerated after each association and dissociation cycle by injecting 10 mM HCl for 10 s. The interaction of ligand and analyte was analyzed using Scrabber 2 Biologic software. Binding kinetics was assessed by determining association (k on ), dissociation (k off ), and equilibrium (K D ) constants.
Animal Model
This study strictly followed the recommendations of National Institute of Health (NIH) for the Care and Use of Laboratory Animals. Animal experiments were reviewed and approved by the Committee on the Ethics of Animal Experiments of the Kyungpook National University (Permit Number: KNU 2012-124). All efforts were made for minimizing animal suffering. Female nude mice (BALB/c nude; body weight, 2063 g; n = 5) were housed in a specific pathogen-free environment at 2262uC, 5565% relative humidity with light. Tumors were generated by subcutaneously injecting MDA-MB-231 cells (5610 6 cells) into the right flank of 5-wk-old BALB/c nude female mice and allowing them to grow for 10days [17, 29] 
Tissue preparation
At 6 h time point, animals were euthanized with CO 2 , tumors and organs were removed from a subset of animals, and ex vivo fluorescence images were collected. The tumor tissues were then fixed by incubating with 4% paraformaldehyde overnight and frozen for cryosectioning. Tissue slices (8-mm thick) were incubated overnight at 4uC with anti-IL-4R antibody (R&D Systems; 1:100) and then incubated for 30 min at room temperature with Alexa 488-labeled goat anti-mouse IgG secondary antibody (1:200). After staining nuclei with DAPI, sections were slide-mounted and observed under a confocal microscope.
Statistical analysis
The statistical significance was determined using Student's t-test for two groups and one-way ANOVA for comparing multiples groups. ***P,0.0001, **P,0.001, and *P,0.05 were considered as statistically significant and denoted by asterisks in the Figures.
Results
Design of [AP1-V 12 ] n genes and protein expression
We successfully constructed [V 12 ] n and [AP1-V 12 ] n gene libraries using the RDL method [11] . The ELP libraries consisted of the monomer genes repeat Val-Pro-Gly-Val-Gly with Valine at the guest residue of ELP pentapeptide (Fig. 1A) , whereas the [AP1-V 12 ] n library contained modified AP1 sequence, in the N-terminal region of the ELP coding sequences (Fig. 1B) 14 ] 6 WPC proteins were purified using the ITC method; the total yield was ,20 mg/ L. After four rounds of ITC, SDS-PAGE followed by Coomassie blue staining showed that [AP1-V 12 ] 6 and [V 14 ] 6 were approximately ,37 kDa and ,35 kDa in size, respectively, with minimal contamination (Fig. 2A) . (Fig. 2B) . Incorporation of the hydrophilic AP1 sequence into the ELP gene increased the T t compared to the ELP control [30] . We observed that the inverse transition of the polymer [AP1-V 12 ] 6 is just above the physiological body temperature, which is preferable for clinical applications.
Thermal characterization
In (Fig. 3A, B) and MDA-MB-231 cells (Fig. 3C, D) after a 1-h incubation at 4uC was higher than that of the non-targeted [V 14 ] 6 polymer (P,0.0001). Both non-targeted [V 14 ] 6 and targeted [AP1-V 12 ] 6 polymers showed significantly lower binding towards H460 cells (Fig. 3E, F (Fig. 3 G, H) .
Cellular localization of [AP1-V 12 ] 6 polymer and affinity for IL-4R
The cellular localization of [AP1-V 12 ] 6 polymer at different temperatures were further confirmed by confocal microscopic imaging, which clearly revealed that [AP1-V 12 ] 6 polymer and AP1 peptide accumulated more efficiently to the cell surface of H226 (Fig. 4A) and MDA-MB-231 (Fig. S2A ) cells at 4uC compared to H460 cells (Fig. S3A) . [AP1-V 12 ] 6 polymer was well internalized when incubated at 37uC whereas no uptake was seen in case of [V 14 ] 6 polymer in both H226 (Fig. 4B) and MDA-MB-231 cells (Fig. S2B) . Both non-targeted [V 14 ] 6 and targeted [AP1-V 12 ] 6 polymers have shown lower cell binding and uptake in case of IL-4R negative H460 cells (Fig. S3A, B) . Thus, these results indicated that cellular uptake of [AP1-V 12 ] 6 polymers were not due to (Fig. 4A, right panel) and internalized into cytoplasm when temperature was increased to 37uC (Fig. 4B, 6 polymers shown similar pattern of cell viability and proliferation at different time intervals (Fig. 5A, B) . Thus, the result indicated that both the polymers are nontoxic to the cancer cell.
We 
Surface plasmon resonance analysis to check [AP1-V 12 ] 6 protein affinity for IL-4R
The kinetics of AP1 peptide and [AP1-V 12 ] 6 protein binding to the IL-4R were analyzed using surface plasmon resonance [31, 32] . The [AP1-V 12 ] 6 polymer (Fig. 6A) showed higher binding affinity than the AP1 peptide (Fig. 6B) 
In vivo imaging of [AP1-V 12 ] 6 polymer tumor targeting
The in vivo tumor-targeting efficiency of the [AP1-V 12 ] 6 polymer was studied using a near-infrared fluorescence (NIRF) live optical imaging system. In vivo fluorescence images taken at different time intervals showed that the [AP1-V 12 ] 6 polymer rapidly accumulated at tumor tissue (within a little as 10 min of injection) in MDA-MB-231 (Fig. 7A, B (Fig. 7C ). An immunohistological examination of tumor tissue showed that abundant staining for [AP1-V 12 ] 6 was confined to the tumor tissue, consistent with our in vivo and ex vivo imaging results (Fig. 7D) .
Discussion
Cancer cells express a number of cell surface and matrix proteins that mediate tumor growth, migration, invasion, and metastasis. Screening for ligands that specifically target these receptors represents an excellent cancer therapy strategy [33, 34] . Initial studies using phage display technology discovered an IL-4R binding peptide (AP1) that was highly expressed on atherosclerotic plaques and cancer cells [16, 17] . The AP1 peptide was found to bind the IL-4R with low affinity (i.e., micromolar dissociation constant), which means that more targeting peptide is necessary to achieve high receptor occupancy. To improve the binding affinity of AP1 as well as its avidity towards the IL-4 receptor, we incorporated multiple AP1 peptides into the ELP polymer.
The genetically encoded synthesis of [AP1-V 12 ] 6 allows easy synthesis of ligand-presenting ELP polymers and makes it possible to control their molecular weight and T t to conform the requirements of physiological conditions. The ELP polymer backbone is capable of accommodating virtually any target specific ligand and can support multivalent presentation of target ligands without a change in its physical properties [35, 36] . Many researchers have investigated the potential of ELP based incorporation of peptide as targeting moieties and cell penetrating peptide to improve the uptake by cancer cells [37, 38] . Moreover there are many reports on application of diblock ELPs polymers consisting of a hydrophilic block and hydrophobic block capable of forming monodisperse spherical micelles above critical micelle temperature (CMT) for presentation of targeting ligands at their N-terminus site which enables multivalent presentation on their selective targets [36, 39] .
In this study for the first time we attempted to design ELP based multivalent targeting polymer by accommodating tandem repeat of highly specific IL-4R binding ligands, AP1 along the ELP polymer to improve its presentation towards IL-4R highly expressed cancer cells. Incorporation of AP1 on ELP elevated the T t compared to ELP alone, likely due to the charged and polar surface residues present on AP1 [30] . Trabbic-Carlson et al. 2004 [30] already reported that the T t of ELP fusion protein was negatively correlated with the fraction of hydrophobic area . (A, B) H226, (C, D) MDA-MB-231 and (E, F) H460 cells were incubated with 10 mM of [V 14 ] 6 , [AP1-V 12 ] 6 and AP1 for 1 h at 4uC. Cell binding was determined using flow cytometry. Histograms are representative of three independent experiments. Graphical bars (on right) represent the percent of Alexa 488 labeled polymer bound to cells as mean 6SD of data obtained from three separate experiments performed in triplicates. ***P,0.0001, **P,0.001, and *P,0.05, one-way ANOVA; n = 3. (G, H) H226 cells (3610 5 cells) were pre-incubated with different concentrations (1, 5 and 10 mg/mL) of anti-IL-4 receptor antibody followed by 1 h incubation with 10 mM Alexa-labeled [AP1-V 12 ] 6 at 4uC. The cells were further suspended in 300 mL of PBS after washing and analyzed using flow cytometry. Histograms are representative of three independent experiments. Graphical bars represent the percent of Alexa 488 labeled polymer bound to cells as mean 6SD of data obtained from three separate experiments performed in triplicates. ***P,0.0001, One way ANOVA; n = 3. doi:10.1371/journal.pone.0081891.g003 AP1-ELP Based Tumor Targeting PLOS ONE | www.plosone.orgpresented on the surface of the fused folded protein. Proteins with relatively high hydrophobic solvent-accessible surface area depressed the inverse transition temperature of the fused ELP whereas proteins with more hydrophilic surfaces slightly increase elevated the transition temperature of the ELP fusion protein relative to that of the ELP.
The multivalent presentation of the targeting ligand AP1 on the ELP polymer backbone increased binding affinity ,10000-fold compared to the free AP1 peptide clearly denoted its augmentation in affinity and IL-4R interaction which is important for tumor targeting approach. In vitro studies further showed significantly higher binding of the [AP1- [18] . Notably, our genetically engineered ELP-based AP1 polymers further enhanced tumor targeting ability, showing high tumor accumulation that was evident as early as 10 min after intravenous injection, peaked after about 6 h, and was maintained up to 24 h (Fig. 7) . With the exception of kidney and liver, fluorescence levels were negligible in off-target organs, including the lung, spleen, and heart. Even though our designed the [AP1-V 12 ] 6 polymer has T t just above the physiological body temperature, which is preferable for clinical applications [42] , T t of [V 14 ] 6 control is found to be relatively lower than the [AP1-V 12 ] 6 . However, the difference in T t was not an emphasis due to application of lesser concentration of nontargeting and targeting polymer during in vivo experiments. Besides, [V 14 ] 6 control was found to accumulate in various organs post intravenous injection except in the tumor tissue unlike the case of [AP1-V 12 ] 6 injected groups with precise localization to tumor tissue. Collectively, these findings highlight the promise of our [AP1-V 12 ] 6 polymer as a candidate macromolecular drug delivery system. Although our ELP-based polymers can target only IL-4R overexpressed cancer cells, many tumor of different origin have been reported to highly expressed IL-4R [19] [20] [21] [22] and thus our designed polymer can be used as a potent drug carrier for various targeted cancer therapies.
The strategy of designing macromolecular carrier systems with multivalent ligand presentation for targeting surface molecules displayed on solid tumors has clear value in clinical applications. Because of relatively simple and novel synthetic process and the ability to use multivalent peptides and targeting moieties, we proposed a method which is distinctive and explore a new arena of multivalent cancer targeting. Although our multivalent targeting system exhibited effective tumor accumulation, further study is needed to realize the promise of ELP-based targeting polymers as carriers for delivering chemotherapeutic agents and therapeutic peptides. Supporting Information 
